Founded in 1952, China Chemical & Pharmaceutical Co., Ltd. (CCPC) is dedicated to the innovation, research and development, manufacturing, and upgrade of services in the pharmaceutical industry. Since its establishment, CCPC has made numerous advances in the development of generic pharmaceutical and healthcare products for use in humans and animals. Widely used in every hospital and family household, the company's advanced medical and health products help ensure better health and quality of life.
Founded in 1988 with visions of professional and innovated services, integrity conducts and passion of humanity, Excelsior is a leading specialty pharmaceutical company in Taiwan. Our core business focus on commercial launch of orphan drugs, specialty medicines for pediatrics metabolic, genetic, and neurological diseases.
Taiwan Panbiotic Laboratories Co., Ltd. was founded in 1971. The Company's line of business includes the manufacturing, fabricating, or processing of drugs in pharmaceutical preparations for human or veterinary use.
With the expectation of pharmaceutical development, Standard has assigned product lines to its subsidiaries, which means each subsidiary can focus on one professional field for profit maximization. Currently, Standard focuses on pharmaceuticals; Syn-tech specializes in API; Syngen covers biotechnology API, health supplements, and medical equipment; Multipower is responsible for the sales of Neoangelac Plus milk powder and adult supplements.
Founded in 1945, Taiwan Biotech (TBC) is the first local pharmaceutical company in Taiwan. We have devoted over 75 years to developing and supplying superior generic drugs that cover a variety of therapeutic areas. TBC has established international business and development division since 1996 to promote the products globally and nurtured a stable and continuously-growing sales network across Japan, Southeast Asia, Mainland China, and North America. We strive to innovate and will continue expanding our global footprint.
Established in 1952, YSP has worked hard to become an international high-tech enterprise, successfully expanding its reach into Europe, the Americas, Asia and Africa, and earning acknowledgement by the international pharmaceutical industry. YSP currently exports multiple products to a number of countries, and has established plants in the U.S., China and Malaysia to expand its overseas market. Our ambition is to lead the way in pharmaceutical industry and contribute to people's health.